Role of Patients’ Education in Uncomplicated UTIs

Managed Care Cast Presents: Leveraging Topical Therapies for Pediatric Atopic Dermatitis

COVID-19 vaccination before infection lowered long COVID risk in adolescents, highlighting vaccines as an effective prevention strategy.

Innovative Payment Models, Holistic Medicaid Approaches Could Improve GLP-1 Access, Outcomes

Experts discuss how topical therapies effectively manage atopic dermatitis in pediatric patients, enhancing outcomes and addressing unique challenges.

Listen

GLP-1 | Image Credit: mingnimit - stock.adobe.com

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

Innovative payer approaches and holistic support could help expand GLP-1 use and improve obesity care outcomes, experts claimed.

October 14th 2025

Combination and Monotherapy Data Highlight Rocatinlimab’s Real-World Potential in AD: A Q&A With Emma Guttman-Yassky, MD, PhD

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

Emma Guttman-Yassky, MD, PhD | Image Credit: © Icahn School of Medicine at Mount Sinai

Lifestyle Changes Reduce AF Recurrence After Ablation

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

Patients who adopt intensive lifestyle and risk factor modifications after ablation show improved long-term atrial rhythm stability. | Image Credit: Shapla - stock.adobe.com

COVID-19 Vaccination Linked to Lower Risk of Long COVID in Adolescents

Aggressive lifestyle and risk factor control after ablation significantly lowers atrial fibrillation recurrence and improves heart health.

Related Content

November 3rd 2025

Managed Care Cast Presents: Leveraging Topical Therapies for Pediatric Atopic Dermatitis

COVID-19 vaccination before infection lowered long COVID risk in adolescents, highlighting vaccines as an effective prevention strategy.

Innovative Payment Models, Holistic Medicaid Approaches Could Improve GLP-1 Access, Outcomes

Experts discuss how topical therapies effectively manage atopic dermatitis in pediatric patients, enhancing outcomes and addressing unique challenges.

Listen

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

Innovative payer approaches and holistic support could help expand GLP-1 use and improve obesity care outcomes, experts claimed.

October 14th 2025

Combination and Monotherapy Data Highlight Rocatinlimab’s Real-World Potential in AD: A Q&A With Emma Guttman-Yassky, MD, PhD

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

Lifestyle Changes Reduce AF Recurrence After Ablation

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.